Enliven Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $36k | 2.3k | 15.40 |
| 2025-09-30 | $32k | 1.6k | 20.47 |
| 2025-06-30 | $106k | 5.3k | 20.06 |
| 2025-03-31 | $35k | 1.8k | 19.68 |
| 2024-12-31 | $36k | 1.6k | 22.50 |
| 2024-09-30 | $12k | 484 | 25.54 |
| 2024-06-30 | $76k | 3.2k | 23.37 |
| 2024-03-31 | $8.9k | 506 | 17.59 |
| 2023-09-30 | $92k | 6.8k | 13.66 |
| 2023-06-30 | $28k | 1.4k | 20.41 |
| 2023-03-31 | $36k | 1.7k | 21.73 |